Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies

The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible decreases in vaccine effectiveness. Here, neutralizing antibody titers elicited by mRNA-based and adenoviral vector-based vaccines against variant pseudotyped viruses were measured. BNT162b2 and mRNA-1273-elicite...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Takuya, Zhou, Hao, Samanovic, Marie I., Dcosta, Belinda M., Cornelius, Amber, Herati, Ramin S., Mulligan, Mark J., Landau, Nathaniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957851/
https://www.ncbi.nlm.nih.gov/pubmed/35350781
http://dx.doi.org/10.3389/fimmu.2022.797589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957851/
https://www.ncbi.nlm.nih.gov/pubmed/35350781
http://dx.doi.org/10.3389/fimmu.2022.797589

Ejemplares similares